πŸ‡ΊπŸ‡Έ FDA
Patent

US 7504243

Methods for the production of biliverdin

granted A61PA61P25/28A61P29/00

Quick answer

US patent 7504243 (Methods for the production of biliverdin) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Mar 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Mar 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61P, A61P25/28, A61P29/00, A61P35/00, A61P9/00